These results revealed that the GLUT1/ALDOB/G6PD axis mediated chemoresistance by modulating glucose metabolism and the levels of pyrimidine nucleosides in pancreatic cancer cells. This evidence concerns the gene SLC2A1 and pancreatic neoplasm.